Evidence map›Paper›PMID 28973457›Full record

ArticleNucleic acids research2017

Direct modulation of T-box riboswitch-controlled transcription by protein synthesis inhibitors.

Vassiliki Stamatopoulou, Maria Apostolidi, Shuang Li, Katerina Lamprinou, Athanasios Papakyriakou, Jinwei Zhang, Constantinos Stathopoulos

Open access · goldAbstract readComparative Study
In one paragraph

Article in Nucleic acids research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. A Riboswitch-Driven Era of New Antibacterials.Antibiotics (Basel, Switzerland) · 2022
    Review
  6. Article
  7. Adaptor Molecules Epitranscriptome Reprograms Bacterial Pathogenicity.International journal of molecular sciences · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Noncoding RNA.Microbiology spectrum · 2019
    Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Vassiliki StamatopoulouDepartment of Biochemistry, School of Medicine, University of Patras, 26504 Patras, Greece.
Maria ApostolidiDepartment of Biochemistry, School of Medicine, University of Patras, 26504 Patras, Greece.
Shuang LiLaboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, 50 South Drive, Bethesda, MD 20892, USA.
Katerina LamprinouDepartment of Biochemistry, School of Medicine, University of Patras, 26504 Patras, Greece.
Athanasios PapakyriakouInstitute of Biosciences and Applications, National Centre for Scientific Research 'Demokritos', Athens, Greece.
Jinwei ZhangLaboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, 50 South Drive, Bethesda, MD 20892, USA.
Constantinos StathopoulosDepartment of Biochemistry, School of Medicine, University of Patras, 26504 Patras, Greece.
University of Patras · GRNational Institute of Diabetes and Digestive and Kidney Diseases · USNational Centre of Scientific Research "Demokritos" · GR

Funding

Noncoding RNA structures and interactions in cellular stress responses and immunityZIADK075136 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI ZHANG, JINWEI · 2016 to 2025
$23.2M
The Center for HIV RNA Studies (CRNA)U54GM103297 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SUMMERS, MICHAEL FINLEY · 2017 to 2018
$10.2M
NIGMS NIH HHS U54 GM103297
6 · The paper itself

Abstract

Recently, it was discovered that exposure to mainstream antibiotics activate numerous bacterial riboregulators that control antibiotic resistance genes including metabolite-binding riboswitches and other transcription attenuators. However, the effects of commonly used antibiotics, many of which exhibit RNA-binding properties, on the widespread T-box riboswitches, remain unknown. In Staphylococcus aureus, a species-specific glyS T-box controls the supply of glycine for both ribosomal translation and cell wall synthesis, making it a promising target for next-generation antimicrobials. Here, we report that specific protein synthesis inhibitors could either significantly increase T-box-mediated transcription antitermination, while other compounds could suppress it, both in vitro and in vivo. In-line probing of the full-length T-box combined with molecular modelling and docking analyses suggest that the antibiotics that promote transcription antitermination stabilize the T-box:tRNA complex through binding specific positions on stem I and the Staphylococcal-specific stem Sa. By contrast, the antibiotics that attenuate T-box transcription bind to other positions on stem I and do not interact with stem Sa. Taken together, our results reveal that the transcription of essential genes controlled by T-box riboswitches can be directly modulated by commonly used protein synthesis inhibitors. These findings accentuate the regulatory complexities of bacterial response to antimicrobials that involve multiple riboregulators.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsDose-Response Relationship, DrugGene Expression Regulation, BacterialGlycineGlycine-tRNA LigaseGram-Negative BacteriaGram-Positive BacteriaModels, MolecularMolecular Docking SimulationNucleic Acid ConformationPhylogenyProtein BindingProtein Synthesis InhibitorsRecombinant Fusion ProteinsRiboswitchAnti-Bacterial AgentsBacterial ProteinsGlycineGlycine-tRNA LigaseProtein Synthesis InhibitorsRecombinant Fusion ProteinsRiboswitchRNA, BacterialRNA, MessengerRNA, TransferRNA, Transfer, GlyT-Box Domain Proteins

Identifiers

PMID28973457
PMCPMC5622331
OpenAlexW2739571708

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.